Pharma & Biotech

BioNTech's equity performance is presenting a conundrum for market participants. The company continues to deliver impressive revenue figures and has...

A recent decision by the European Patent Office has positioned BioNxt Solutions for a potential breakthrough in multiple sclerosis treatment....

CureVac investors face a pivotal moment as BioNTech's acquisition proposal moves toward a decisive shareholder vote. The extraordinary general meeting...

Dare Bioscience shares displayed modest gains during Friday's trading session, but market observers question whether this signals a genuine reversal...

Oruka Therapeutics has positioned itself for significant growth following a substantial $164 million capital infusion. According to SEC filings made...

Emergent BioSolutions shares have experienced significant turbulence following the company's impressive third-quarter 2025 earnings release. Despite reporting financial results that...

Trinity Biotech's stock continues to navigate challenging market conditions as bearish signals dominate the technical landscape. The company's shares have...

Clinical-stage biopharmaceutical company NovaBridge Biosciences, formerly known as I-Mab, has released compelling updated Phase 1 data for its bispecific antibody...

The biotechnology firm Minerva Neurosciences is approaching a definitive period in its corporate history. The company's future prospects are now...

The shares of biotechnology firm Scynexis are trading deep in negative territory, yet a recent $25 million agreement with pharmaceutical...